- Nancydrew2
- Sex: F
- Data Quality: 0 stars
- MS: 30 yrs
- Type: Relapsing-Remitting
- Sensation: Moderate
- Overall: Mild
- Cognition: moderate
- Vision: moderate
- Speech: mild
- Swallowing: mild
- Upper limb: mild
- Walking: mild
- Nancydrew2
- Female, 67 years
- IL, United States
-
- Nancydrew2
- Sex: F
- Data Quality: 0 stars
- Sensation: Moderate
- Overall: Mild
- Cognition: moderate
- Vision: moderate
- Speech: mild
- Swallowing: mild
- Upper limb: mild
- Walking: mild
- I am: g
I have:MSNancydrew2 completed the MSRS survey for Mar 20, 2012 Mar 26, 2012MSRS: 39
- Cognition
- Vision
- Speech
- Swallowing
- Upper Limb
- Walking
- Sensation
-
- Nancydrew2
- Sex: F
- Data Quality: 0 stars
- Sensation: Moderate
- Overall: Mild
- Cognition: moderate
- Vision: moderate
- Speech: mild
- Swallowing: mild
- Upper limb: mild
- Walking: mild
- I am: g
I have:MSNancydrew2 added a mild relapse on Mar 20, 2012 until Mar 21, 2012 Mar 26, 2012Relapse
-
- Nancydrew2
- Sex: F
- Data Quality: 0 stars
- Sensation: Moderate
- Overall: Mild
- Cognition: moderate
- Vision: moderate
- Speech: mild
- Swallowing: mild
- Upper limb: mild
- Walking: mild
- I am: g
I have:MSNancydrew2 added the treatment Dalfampridine (4-AP extended release) Dec 22, 2011Dalfampridine (4-AP extended release)
- Started: ?
- Dosage: ?
- Purpose: MS
